ABVC BioPharma, Inc. (ABVC)

SG&A Expenses

$6.15M

TTM · Period ending: · USD

ABVC logo

ABVC SG&A Expenses

Latest reported$6.15M
ABVC TTM SG&A Expenses ($30.00K → $6.15M)
High-resolution chart · PNG

ABVC sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

ABVC BioPharma, Inc. SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
6,147,473
7,905,402
7,030,174
5,164,465
3,883,466
2,565,939
4,671,912
6,120,152
7,466,514
8,134,862
7,003,986
7,212,387
8,654,440
8,860,483
13,104,323
17,289,909
15,653,759
15,542,620
11,052,874
9,634,129
9,090,592
8,660,368
8,420,447
4,644,488
4,409,346
3,695,916
3,047,915
2,466,682
1,771,037
1,664,653
1,573,908
1,510,567
1,839,147
1,553,732
1,350,755
1,228,850
1,216,575
1,333,694
1,230,735
1,048,870
401,153
112,055
3,323
1,030
1,030
1,030
1,030
0
0
0
129,466
374,913
709,131
1,170,157
1,458,306
1,986,214
1,981,432
1,891,053
1,816,731
1,385,104
1,486,313
1,904,251
2,319,829
2,665,800
3,069,430
4,910,845
5,209,906
5,837,351
6,556,076
5,379,332
8,751,400
7,449,808
5,908,948
4,465,358
36,695
30,705
26,825
16,679
21,988
18,533
17,574
23,000
23,814
27,034
23,098
28,152
30,692
33,365
30,000
30,000
30,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.